MRC1 and neoplasm: While potentiation of TMZ treatment can be enhanced by inhibiting the mechanisms behind drug resistance, novel approaches to inhibit the effects of MGMT, BER, and MMR, that invariably arm tumor cells with the ability to combat TMZ activity, must be developed and implemented.